Cibus, Inc. (CBUS)
Cibus, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $1.90, down 0.79% on the session, giving a market capitalisation of $145.0M. On trailing twelve-month figures it carries a trailing P/E of -1.07, a net margin of -2366.3%. Its beta of 1.62 implies it has historically moved more than the broad market.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cibus, Inc. is most often compared with the following Healthcare names: